[ Diabetes Type 2 ]

Adipose tissue and diabetes therapy: do we hit the target? – PubMed

Diabetes and its major risk factor, obesity, have become a world-wide epidemic and cause of suffering for millions of people. For its part, diabetes is known to worsen survival of BC patients although there is no evidence of a pathway by which antidiabetic therapy might influence the key prognostic feature of BC tissue–the tumor receptor phenotype. β-Cell function was assessed using a mixed-meal challenge test at randomization and 6, 12, 18, 30, and 42 months. Several regulatory binding sites have been identified in GP, such as the catalytic, the allosteric, and the inhibitor binding sites. Exenatide QW has been shown to provide continuous glucose control by gradually releasing exenatide, the active ingredient in exenatide twice daily, from subcutaneously injected microspheres.8 Exenatide-containing microspheres, which are about the diameter of a human hair, are made of the same material as dissolvable sutures and release exenatide by diffusion during degradation (Figure 1).9 The microspheres are administered through a 23-gauge needle after resuspension with vigorous shaking. Credit can only be claimed once for this activity. We have identified new stress-causing cytokines and shown that blocking them partially improves control of blood glucose, offering several new targets for therapy.

DeFronzo, MD, professor of medicine, and chief of the Diabetes Research Unit at the University of Texas Health Sciences Center in San Antonio, argued in favor of triple and quadruple therapies; Thomas R.

Tags: , ,